A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study.
BACKGROUND:Despite the use of closed system drug transfer devices (CSTD), residual contamination from antineoplastic drugs is still detected inside isolators. The aim of this study was to compare the decontamination level obtained using a CSTD + standard cleaning procedure with a CSTD + standard cle...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6082556?pdf=render |
id |
doaj-8fbe8420affb4824bdde18b8510dc4d2 |
---|---|
record_format |
Article |
spelling |
doaj-8fbe8420affb4824bdde18b8510dc4d22020-11-24T21:35:15ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-01138e020133510.1371/journal.pone.0201335A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study.Michèle VasseurNicolas SimonChloé PicherCamille RichevalMarion SoichotLuc HumbertChristine BarthélémySandrine Fleury-SouverainPascal BonnabryBertrand DécaudinDelphine AllorgePascal OdouBACKGROUND:Despite the use of closed system drug transfer devices (CSTD), residual contamination from antineoplastic drugs is still detected inside isolators. The aim of this study was to compare the decontamination level obtained using a CSTD + standard cleaning procedure with a CSTD + standard cleaning procedure + specific decontamination procedure. METHODS AND FINDINGS:A comparative and prospective study was carried out in a newly opened compounding unit. Compounding was performed with a CSTD (BD-Phaseal, Becton-Dickinson). In the Control isolator (C), the cleaning process was completed daily with a standard biocide solution (AnioxysprayTM, Anios, France). In the Intervention isolator (I), weekly decontamination with a homemade admixture of sodium dodecyl sulfate 10(-2) M/70% isopropanol (80/20, v/v) was added. Monitoring was performed via a validated LC-MS/MS method. Eight drugs (cyclophosphamide, cytarabine, dacarbazine, fluorouracile, gemcitabine, ifosfamide, irinotecan and methotrexate) were monitored daily over 14 consecutive weeks on three sites inside the isolators: gloves, workbench and window. Results are presented as the odds-ratio (OR) of contamination and as overall decontamination efficiency (EffQ, %). The proportion of EffQ ≥ 90% was assessed by a Fisher's exact test (p<0.05). Overall contamination rates (CR, %) were significantly different from one isolator to the other (CRC = 25.3% vs. CRI = 10.4%; OR = 0.341; p<0.0001). Overall EffQ values (median; 1st and 3rd quartiles) were higher in the intervention isolator (I: 78.3% [34.6%;92.6%] vs. C: 59.5% [-5.5%;72.6%]; p = 0.0015) as well as the proportion of days with an EffQ ≥ 90% (I: 42.9% vs. C: 7.1%; p = 0.077) but very variable depending on drugs. CONCLUSION:Adding a decontamination protocol with a tensioactive agent to a CSTD leads to better control of chemical contamination inside isolators. Improving decontamination by increasing decontamination frequency or modifying the protocol will be further studied.http://europepmc.org/articles/PMC6082556?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Michèle Vasseur Nicolas Simon Chloé Picher Camille Richeval Marion Soichot Luc Humbert Christine Barthélémy Sandrine Fleury-Souverain Pascal Bonnabry Bertrand Décaudin Delphine Allorge Pascal Odou |
spellingShingle |
Michèle Vasseur Nicolas Simon Chloé Picher Camille Richeval Marion Soichot Luc Humbert Christine Barthélémy Sandrine Fleury-Souverain Pascal Bonnabry Bertrand Décaudin Delphine Allorge Pascal Odou A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study. PLoS ONE |
author_facet |
Michèle Vasseur Nicolas Simon Chloé Picher Camille Richeval Marion Soichot Luc Humbert Christine Barthélémy Sandrine Fleury-Souverain Pascal Bonnabry Bertrand Décaudin Delphine Allorge Pascal Odou |
author_sort |
Michèle Vasseur |
title |
A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study. |
title_short |
A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study. |
title_full |
A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study. |
title_fullStr |
A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study. |
title_full_unstemmed |
A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study. |
title_sort |
decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. a prospective, parallel study. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2018-01-01 |
description |
BACKGROUND:Despite the use of closed system drug transfer devices (CSTD), residual contamination from antineoplastic drugs is still detected inside isolators. The aim of this study was to compare the decontamination level obtained using a CSTD + standard cleaning procedure with a CSTD + standard cleaning procedure + specific decontamination procedure. METHODS AND FINDINGS:A comparative and prospective study was carried out in a newly opened compounding unit. Compounding was performed with a CSTD (BD-Phaseal, Becton-Dickinson). In the Control isolator (C), the cleaning process was completed daily with a standard biocide solution (AnioxysprayTM, Anios, France). In the Intervention isolator (I), weekly decontamination with a homemade admixture of sodium dodecyl sulfate 10(-2) M/70% isopropanol (80/20, v/v) was added. Monitoring was performed via a validated LC-MS/MS method. Eight drugs (cyclophosphamide, cytarabine, dacarbazine, fluorouracile, gemcitabine, ifosfamide, irinotecan and methotrexate) were monitored daily over 14 consecutive weeks on three sites inside the isolators: gloves, workbench and window. Results are presented as the odds-ratio (OR) of contamination and as overall decontamination efficiency (EffQ, %). The proportion of EffQ ≥ 90% was assessed by a Fisher's exact test (p<0.05). Overall contamination rates (CR, %) were significantly different from one isolator to the other (CRC = 25.3% vs. CRI = 10.4%; OR = 0.341; p<0.0001). Overall EffQ values (median; 1st and 3rd quartiles) were higher in the intervention isolator (I: 78.3% [34.6%;92.6%] vs. C: 59.5% [-5.5%;72.6%]; p = 0.0015) as well as the proportion of days with an EffQ ≥ 90% (I: 42.9% vs. C: 7.1%; p = 0.077) but very variable depending on drugs. CONCLUSION:Adding a decontamination protocol with a tensioactive agent to a CSTD leads to better control of chemical contamination inside isolators. Improving decontamination by increasing decontamination frequency or modifying the protocol will be further studied. |
url |
http://europepmc.org/articles/PMC6082556?pdf=render |
work_keys_str_mv |
AT michelevasseur adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT nicolassimon adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT chloepicher adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT camillericheval adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT marionsoichot adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT luchumbert adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT christinebarthelemy adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT sandrinefleurysouverain adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT pascalbonnabry adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT bertranddecaudin adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT delphineallorge adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT pascalodou adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT michelevasseur decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT nicolassimon decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT chloepicher decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT camillericheval decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT marionsoichot decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT luchumbert decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT christinebarthelemy decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT sandrinefleurysouverain decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT pascalbonnabry decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT bertranddecaudin decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT delphineallorge decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy AT pascalodou decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy |
_version_ |
1725945695813238784 |